Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154697 · ClinicalTrials.gov registry record
Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances
A clinical trial of Sleep Disturbances in Smith-Magenis Syndrome, sponsored by Vanda Pharmaceuticals.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT03154697: Recruiting study of Sleep Disturbances in Smith-Magenis Syndrome, sponsored by Vanda Pharmaceuticals.
NCT03154697 is a study of Sleep Disturbances in Smith-Magenis Syndrome that is actively recruiting participants, run by Vanda Pharmaceuticals. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03154697, a study of Sleep Disturbances in Smith-Magenis Syndrome, is actively recruiting participants, sponsored by Vanda Pharmaceuticals.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
Conditions Studied
Interventions
- OTHER Data collection of sleep disturbances in individuals with SMS
Study Locations (1)
District of Columbia
- Vanda Pharmaceuticals - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2016-01 |
| Est. Completion | 2030-12 |
What NCT03154697 shows while recruiting
NCT03154697 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Sleep Disturbances in Smith-Magenis Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Data collection of sleep disturbances in individuals with SMS is the first listed.
NCT03154697 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT03154697 about?
NCT03154697 is a clinical study titled "Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances". This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
What is the current status of trial NCT03154697?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-01. Estimated completion is 2030-12.
What conditions does trial NCT03154697 study?
This clinical trial studies the following conditions: Sleep Disturbances in Smith-Magenis Syndrome.
What interventions are being tested in trial NCT03154697?
The interventions under investigation include: Data collection of sleep disturbances in individuals with SMS (OTHER).
Who is sponsoring clinical trial NCT03154697?
This trial is sponsored by Vanda Pharmaceuticals, which has 68 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03154697 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia